• 幫助潔淨結腸

• 有助保持腸道平衡

• 支援身體吸收營養

• 有助保持消化系統健康

• 有助維持正常的腸道內菌叢生態

• 有助緩解偶發性便秘†

• 促進正常的排便規律和排便量

• 促進結腸健康

• 促進結腸內益菌的健康生長

• 為小腸的細胞提供養分

• 支援健康的腸道功能

• 或有助於穩定膽固醇及血糖水平* 

• 促進免疫系統，支持整體健康

不含麩質 - 本產品不含可檢測出之麩質*

不含可檢測出之基改成份(GMO) - 本產品不含可檢測出之基因改造生物成份

素食品 - 本產品為素食產品

品質標準 - 良好生產規範(GMP)運作與標準化成份

已檢測：重金屬丶微生物污染物丶過敏原丶效力丶純度及特性

*美國食品藥品監督管理局（FDA）將含有少於20PPM麩質的製成產品列為不含麩質

Fibersol-2™±（可溶性纖維葡萄糖聚合物複合物） 
Fibersol-2 是一種水溶性纖維，對排走廢物及腸道清洗有正面效果，同時有助維持腸道平衡，有助支援正常的排便規律及排便量，亦有助維持消化系統健康。*

± Fibersol是由ADM/Matsutani LLC.製造的可溶性膳食纖維.

菊糖纖維（菊苣根果寡糖萃取物）
菊糖纖維是一種益菌素纖維，提供益生元。菊糖或低聚果糖是澱粉形態的纖維，人體不能完全消化。當人體進食益生元時，未能消化的部分為消化道的益菌提供養分。菊糖可促進益菌數量增長，如結腸內的雙叉桿菌(bifidobacteria)。雙叉桿菌可有助平衡消化道內的細菌。*

益生菌混合物（嗜乳酸桿菌、胚芽乳酸桿菌、雙歧雙叉桿菌及酪蛋白乳酸桿菌）
益生菌是對身體健康有益的細菌，有助維持消化道細菌的最佳平衡。消化系統內數以兆計的天然益菌能直接幫助身體消化、調整及轉化我們攝取的食物。造成益菌量減少是正常的，但益菌量必須維持在足夠水平，以壓倒其他細菌，避免當益菌數量降低時，其他細菌會開始大量滋長。透過取代其他細菌及酵母菌的功能，益生菌如嗜乳酸桿菌、胚芽乳酸桿菌、雙歧雙叉桿菌及酪蛋白乳酸桿菌，或有助維持結腸及免疫系統健康。乳酪及古克非爾（Kefir）等食品含有天然益菌。*

人類與動物研究都證明，恆常攝取益生菌對免疫系統功能有直接好處。總而言之，益生菌可支援免疫系統辨識並消滅入侵性微生物。免疫系統內中幾位主要的「戰士」，包括吞噬細胞、免疫球蛋白及細胞激素，或可從恆常益菌攝取而獲益。攝取益菌還能有助維持健康的白血球數量。*

左旋麩醯胺酸 1,000毫克
左旋麩醯胺酸是由同樣屬於氨基酸的麩醯胺酸所衍生出來的氨基酸。麩醯胺酸是一種有助恢復健康的氨基酸，是消化道的能源。麩醯胺酸能有助維持正常的膽固醇水平及血糖水平，並促進免疫系統健康，從而支援整體健康。劇烈運動會大量損耗人體的麩醯胺酸儲備，尤其是肌肉細胞內的麩醯胺酸。由於腸道細胞使用麩醯胺酸作能源，左旋麩醯胺酸補充品或可有助促進消化健康。*

為甚麼維持腸道健康如此重要？
有些人在出現脹氣、消化不良、排便不規律或腹瀉等問題時，才會留意自身的消化系統。一般人從日常的飲食中未能攝取足夠的纖維素。日積月累，缺乏某些營養素與纖維的飲食會延長還未完全消化的食物在腸道中停留的時間。而且，殘留物中的毒素、細菌以及未消化的食物也會導致偶發性便秘。鑑於以上原因，恆常潔淨腸道才可一直維持健康腸道健康。

為甚麼纖維對整體健康如此重要？
一般人從他們的日常飲食中未能攝取足夠的纖維素。但事實上，我們往往忽略了纖維應該是日常飲食中最重要的要素之一。纖維的好處包括有助維持健康的膽固醇、三酸甘油酯和血糖水平、維持腸道運作規律及維護健康的腸道微生物群生態（為益菌提供養分）。*

甚麼是Fibersol-2？
Fibersol-2是一種嶄新及動態型的可溶性膳食纖維。它以玉米粉為原料，具抗消化性，這意味著它無法被血液吸收。Fibersol-2或有助維持健康的血糖水平、排便規律及腸道健康。香港人一般經常進食缺乏或沒有營養價值的加工食品，因此透過額外食用纖維及Fibersol-2營養補充品，可為身體帶來好處。

*

甚麼是益生菌？
益生菌是活的「好」細菌。普遍認為，它對消化系統提供多種好處，有助於維持胃腸道中微生物群的自然平衡。*

NutriClean 腸道營養纖維粉和一般市面商店購買的纖維粉有何不同？
儘管市面上出售的許多膳食纖維產品或可產生通便效果，但腸道營養纖維粉在支援腸道健康方面遙遙領先。與常見僅具通便效果的纖維不同，腸道營養纖維粉含有左旋麩醯胺酸，為消化系統提供能源。此外，我們的特別配方只採用經廣泛研究、最頂尖的優質膳食纖維，包括菊糖纖維和Fibersol-2。此外，腸道營養纖維粉含有15億菌落數的益生菌維持腸道菌群平衡，為促進整體健康發揮不可或缺的作用。 *

我該如何飲用NutriClean 腸道營養纖維粉？ 
將一圓匙的NutriClean腸道營養纖維粉加入一杯237毫升的冷開水中加以攪拌，並即時飲用。使用此產品時請多飲水。每天食用一匙美安香港的NutriClean腸道營養纖維粉，能為你提供9克的所需纖維，以補充日常飲食的不足。

本產品是否標示「不含可檢測出之基因改造生物」？
本產品未檢測出基因改造生物。本產品的原材料中或許含有基因改造的大豆及／或玉米，但其最終產品並不含任何轉殖基因片段或轉殖蛋白質。

誰應該使用NutriClean腸道營養纖維粉?
香港衞生署建議，成人每天應從飲食中攝取25克或以上的纖維，但大部份膳食只能供給10-15克的纖維。因此，我們絕大多數都難以每天攝取足夠的膳食纖維。此外，由於膳食纖維和益生菌對主要身體系統的健康有重要影響（包括心臟、免疫和消化系統），對一般典型飲食，攝入過多加工食品及缺乏營養價值的人士而言，使用美安NutriClean腸道營養纖維粉作為膳食補充，大有裨益。

使用NutriClean腸道營養纖維粉是否安全？
此產品安全及不含有害物質。產品在美國製造，並使用經美國食品及藥物管理局檢測的設備生產，符合良好生產規範。顧客可對本產品的品質和安全有信心。

• Agarwal K et al. Feasibility studies to control acute diarrhoea in children by feeding fermented milk preparations Actimel and Indian Dahi. European Journal of Clinical Nutrition. 56(Supplement 4): S56-S59, 2002.
• Akisu M et al. The role of dietary supplementation with L-glutamine in inflammatory mediator release and intestinal injury in hypoxia/reoxygenation- induced experimental necrotizing enterocolitis. Annals of Nutrition and Metabolism. 47(6):262-266, 2003.
• Arunachalam K et al. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). European Journal of Clinical Nutrition. 54(3):263-7, 2000.
• Brighenti F et al. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. European Journal of Clinical Nutrition. 53(9):726-733, 1999.
• Cashman K. A prebiotic substance persistently enhances intestinal calcium absorption and increases bone mineralization in young adolescents. Nutrition Reviews. 64: 189-96, 2006.
• Cummings J et al. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Alimentary Pharmacology and Therapeutics. 15:1139–1145, 2001.
• Cunningham-Rundles S et al. Probiotics and immune response. American Journal of Gastroenterology. 95(1 Suppl):S22-5, 2000.
• Davidson M et al. Effects of dietary inulin in serum lipids in men and women with hypercholesterolaemia. Nutrition Research 3:503–17, 1998.
• de Roos N et al. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. American Journal of Clinical Nutrition. 71(2):405-11, 2000.
• Evans M et al. Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells. Journal of Nutrition. 133(10):3065-3071, 2003.
• Fernandes C et al. Control of diarrhea by lactobacilli. Journal of Applied Nutrition. 40:32-43, 1988.
• Flickinger E. Glucose-based oligosaccharides exhibit different in vitro fermentation patterns and affect in vivo apparent nutrient digestibility and microbial populations in dogs. Journal of Nutrition 130:1267-73, 2000.
• Furukawa S et al. Glutamine-enhanced bacterial killing by neutrophils from postoperative patients. Nutrition. 13(10):863-869, 1997.
• Gibson G et al. Selective stimulation of bifidobacteria in the human colony by oligofructose and inulin. Gastroenterology. 108:975-982, 1995.
• Gibson G. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. Journal of Nutrition 129: 1438S-1441S, 1999.
• Halpern G et al. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. American Journal of Gastroenterology. 91(8):1579-1585, 1996.
• Jackson K. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. British Journal of Nutrition. 82:23–30, 1999.
• Kleessen B et al. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. American Journal of Clinical Nutrition. 65(5):1397-1402, 1997.
• Matsuzaki T and Chin J. Modulating immune responses with probiotic bacteria. Immunology and Cell Biology. 78(1):67-73, 2000.
• Miller A. The pathogenesis, clinical implications, and treatment of intestinal hyperpermeability. Alternative Medicine Review. 2(5):330-345, 1997.
• Miller A. Therapeutic considerations of L-glutamine: a review of the literature. Alternative Medicine Review. 4(4): 239-48, 1999.
• Niedzielin K et al. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. European Journal of Gastroenterology and Hepatology. 13(10):1143-1147, 2001.
• Nobaek S et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. American Journal of Gastroenterology. 95(5):1231-1238, 2000.
• Noyer C et al. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. American Journal of Gastroenterology. 93:972-975, 1998.
• Olesen M et al. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. American Journal of Clinical Nutrition. 72:1570–5, 2000.
• Pedone C et al. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. International Journal of Clinical Practice. 53(3):179-184, 1999.
• Perdigon G et al. Systemic augmentation of the immune response by mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology. 63:17-23, 1988.
• Quan Z et al. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World Journal of Gastroenterology. 10(13):1992-1994, 2004.
• Reeds P and Burrin D. Glutamine and the bowel. Journal of Nutrition. 131:2505S-8S, 2001.
• Roberfroid M et al. The bifidogenic nature of chicory inulin and its hydrolysis products. Journal of Nutrition 128:11-9, 1998.
• Roberfroid M. Prebiotics and probiotics: are they functional foods? American Journal of Clinical Nutrition. 71(Supplement):1682S-1687S, 2000.
• Roberfroid M. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. Journal of Nutrition 132(12):3599-602, 2002.
• Roberfroid M. Functional effects of food components and the gastrointestinal system: chicory fructo-oligosaccharides. Nutrition Reviews 54:S38-42, 1996.
• Rolfe R et al. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition. 130(Supplement):396S-402S, 2000.
• Schultz M et al. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clinical and Diagnostic Laboratory Immunology. 11(3):581-587, 2004.
• Tokunaga K and Matsuoka A, "Effects of a [FOSHU] which contains indigestible dextrin as an effective ingredient on glucose and lipid metabolism," J Japanese Diabetes Society, 42:61-65, 1999.
• van der Hulst R et al. Glutamine and the preservation of gut integrity. Lancet. 341:1363–1365, 1993.
• Van Niel C et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109(4):678-684, 2002.
• Wakabayashi S et al. Effects of indigestible dextrin on glucose tolerance in rats. Journal of Endocrinology. 144:533-538, 1995.
• Williams C. Effects of inulin on lipid parameters in humans. Journal of Nutrition. 129(7 Suppl):1471S-1473S, 1999.
• Yalcin S et al. Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in children with acute diarrhea. Journal of Pediatric Gastroenterology and Nutrition. 38(5):494-501, 2004.
• Yasui H et al. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clinical and Diagnostic Laboratory and Immunology. 11(4):675-679, 2004.
• Zoli G et al. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn's disease. Gastroenterology. 108:A766, 1995.